Clinical Research

New COPD Study

Western States Clinical Research is conducting a study for glycopyrronium bromide, which is a long acting muscarinic antagonist. They are looking for people with COPD who are 40 and older who currently smoke or used to smoke. Participants can be on oxygen for less than 12 hours per day - not including night time use or while exercising. Click here for more information.